New European Commission President27/08/2019
The European Commission – another key co-legislator of the European Union policies with impact on childhood cancer care and research – also has a new President-Elect: Ursula von der Leyen (Germany).
New 5-year European Parliament Term27/08/2019
The new European Parliament term (2019-2024) has just began with 751 new Members elected from 28 EU member States. SIOP Europe is delighted that 13 MEPs who had endorsed our European Elections Manifesto have been re-elected.
Prof Ruth Ladenstein nominated to the Mission Board for Cancer27/08/2019
Prof Ruth Ladenstein (CCRI Austria, ERN PaedCan Coordinator and SIOP Europe Board Member) is nominated to the Mission Board for Cancer.
Recommendations for the organisation of care in paediatric radiation oncology across Europe (JARC)17/07/2019
Disparities in survival and long-term side-effects from paediatric cancer are observed across European Society for Paediatric Oncology (SIOPE)-affiliated countries.
EU Work-Life Balance Directive: Paediatric cancer community calls for strong provisions for parents08/07/2019
Parents have a fundamental role in caring for their child throughout the patient pathway. They provide nurturing and support and help minimise the psychological impact associated with a paediatric cancer diagnosis and its treatment.
Press Release: SIOP Europe 2019 Annual Meeting, Prague22/05/2019
A truly successful launch of the first edition of the SIOP Europe Annual Meeting – an innovative setting for Paediatric Oncology and Haematology (20-24 May 2019 in Prague, Czech Republic).
SIOP Europe Annual Report 2018: 20 Years of Progress in Paediatric Haemato-Oncology in Europe22/05/2019
We are delighted to present the first Annual Report of the European Society for Paediatric Oncology (SIOP Europe).
New conect4children Consortium Selects Inaugural Research Portfolio to Advance Development of Innova29/04/2019
c4c today announced the selection of its first portfolio of pan-European paediatric studies aimed at advancing the understanding of high priority medicines commonly used in babies, children and young people in Europe.
The European Reference Network on Paediatric Cancer (ERN PaedCan)23/04/2019
ERN PaedCan will reduce inequalities in childhood cancer survival by providing high-quality, accessible and cost-effective cross-border healthcare to children and adolescents with cancer, regardless of where they live.
SIOPE Newsletter: April 2019 issue